INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC

Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. ("Alignment" or the "Company") (NASDAQ: ALHC ). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Alignment and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. On July 8, 2026, news emerged that a former Alignment Healthcare executive had filed a whistleblower complaint alleging that the Company engaged in "accounting irregularities" that "artificially inflated" Alignment's previously reported and projected financial results, including "Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ('Adjusted EBITDA'), a key non-GAAP financial metric central to the Company's reported financial performance and executive compensation structure." According to the lawsuit, "millions of dollars in operating expenses had been systematically misclassified as capital expenditures." On this news, Alignment's stock price fell $4.02 per share, or 16.7%, to close at $20.03 per share on July 8, 2026.